CD8A and neoplasm: Potential prognostic markers for the response to RCT include the human papillomavirus (HPV) infection status, tumor infiltrating lymphocytes (TILs), such as CD8+ cytotoxic T cells and CD3− NK cells, and the Hsp70 and PD-L1 expression of the tumor.